Beam Therapeutics

In News

[144] Beam Therapeutics Inc. SEC Filing - Stock Titan

Stock Titan - Mar 31, 2026

Beam Therapeutics (BEAM) Is Down 9.9% After Advancing BEAM-302 Into FDA Accelerated Approval Pathway - simplywall.st

simplywall.st - Mar 28, 2026

Beam Therapeutics Clears Technical Benchmark, Hitting 80-Plus RS Rating - MSN

MSN - Mar 29, 2026

Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development - GlobeNewswire

GlobeNewswire - Mar 25, 2026

Beam Therapeutics Inc. (BEAM) Discusses Topline Phase I/II Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency - Slideshow (NASDAQ:BEAM) 2026-03-27 - Seeking Alpha

Seeking Alpha - Mar 27, 2026

JPMorgan Chase & Co. Has $13.14 Million Stock Position in Beam Therapeutics Inc. $BEAM - MarketBeat

MarketBeat - Mar 28, 2026

How The Investment Story For Beam Therapeutics (BEAM) Is Quietly Shifting With New Data And Funding - Yahoo Finance

Yahoo Finance - Mar 27, 2026

Beam Therapeutics stock holds at Outperform on AATD data - Investing.com

Investing.com - Mar 26, 2026

Beam sets hopes on accelerated approval of AATD gene therapy - clinicaltrialsarena.com

clinicaltrialsarena.com - Mar 26, 2026

Beam Therapeutics (BEAM) Soars During the Day – 9.95% Jump Sparks Market Buzz - Bitget

Bitget - Mar 31, 2026

Why Beam Therapeutics Shares Are Suddenly Sinking - TipRanks

TipRanks - Mar 27, 2026

BEAM (NASDAQ: BEAM) affiliate notifies sale of 25,000 shares via option exercise - Stock Titan

Stock Titan - Mar 31, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment